Skip to main content
SpringerLink
Log in

The role of the carnitine system in myocardial fatty acid oxidation: carnitine deficiency, failing mitochondria and cardiomyopathy

  • Conference paper
Lipid metabolism in the normoxic and ischaemic heart

Summary

The carnitine system functions in the transport of activated acyl groups over the mitochondrial inner membrane, and is needed for oxidation of long-chain fatty acids by all mitochondria. The rate of cardiac fatty acid oxidation is determined by availability of fatty acids, oxygen and the activity of carnitine palmitoyltransferase I, which is regulated by a variety of factors. It is inhibited by malonyl-CoA, which in rat heart was found to be synthesized by acetyl-CoA carboxylase. It is also inhibited by long-chain acylcarnitine. Linoleoylcarnitine was found to be a better inhibitor than palmitoylcarnitine. The concentration of carnitine in human heart, muscle and other tissues is much higher than is needed for the optimal β-oxidation rate. In contrast to controls, we found in several myopathie patients that extra carnitine (from ½ to 5 mM) caused a considerable increase in β-oxidation rate of isolated muscle mitochondria. In some of these patients we detected medium-chain acyl-CoA dehydrogenase deficiency.

Patients with primary carnitine deficiency caused by a renal carnitine leak often show cardiomyopathy, which completely disappears under carnitine therapy. Cardiomyopathy may also be the cause of secondary carnitine deficiency resulting from a mitochondrial defect in acyl-CoA metabolism, or by the mitochondrial defect itself, which may be induced by drugs or viral attack, or be the result of a genetic error. In cardiomyopathic patients with a (subclinical) myopathy, study of isolated mitochondria and homogenate from skeletal muscle may reveal a mitochondrial dysfunction, which, in some patients, is treatable by dietary measures and supplementation with vitamins, CoQ and/or carnitine. When the cause of cardiomyopathy is not known, determination of plasma carnitine and carnitine supplementation of hypocarnitinemic patients is of great therapeutic value.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alberts DS, Pen Y-M, Moon TE, Bressler R (1978) Carnitine prevention of adriamycin toxicity in mice. Biomedicine 29: 265–268

    PubMed  CAS  Google Scholar 

  2. Barth PG, Scholte HR, Berden JA, van der Klei-van Moorsel JM, Luyt-Houwen IEM, van ‘t Veer-Korthof ETh, van der Harten JJ, Sobotka-Plojhar MA (1983) An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J Neurol Sci 62: 327–355

    CAS  Google Scholar 

  3. Biaggini A, Opie L, Rovai D, Mazzei MG, Carpeggiani C, Maseri A. (1983) Intravenous DL-carnitine fails to increase the double product during atrial pacing in patients with effort angina. A double blind randomized study. G Ital Cardiol 13: 291–294

    Google Scholar 

  4. Bieber LL, Farrell S (1983) Carnitine acyltransferases. The enzymes 16: 627–644

    Article  CAS  Google Scholar 

  5. Bohmer T, Bergrem H, Eiklid K (1978) Carnitine deficiency induced during intermittent hemodialysis for renal failure. Lancet 1: 126–128

    Article  PubMed  CAS  Google Scholar 

  6. Bookelman H, Trijbels JMF, Sengers RCA, Janssen AJM (1978) Measurement of cytochromes in human skeletal muscle mitochondria isolated from fresh and frozen stored muscle specimens. Biochem Med 19: 366–373

    Article  PubMed  CAS  Google Scholar 

  7. Borum PR (1983) Carniture. Ann Rev Nutr 3: 233–259

    Article  CAS  Google Scholar 

  8. Bremer J (1983) Carnitine-metabolism and functions. Physiol Rev 63: 1320–1479

    Google Scholar 

  9. Bremer J, Osmondsen H (1984) Fatty acid oxidation and its regulation. In: Numa S (ed) Fatty acid metabolism and its regulation, Elsevier, Amsterdam, pp 113–154

    Chapter  Google Scholar 

  10. Bressler R, Wittels B (1965) The effect of diphteria toxin on carnitine metabolism in the heart. Biochim Biophys Acta 104: 39–45

    Article  PubMed  CAS  Google Scholar 

  11. Brownsey RW, Denton RM (1982) Evidence that insulin activates fatcell acetyl-CoA carboxylase by increased phosphorylation at a specific site. Biochem J 202: 77–86

    PubMed  CAS  Google Scholar 

  12. Chaloner DR, Mandelbaum I, Elliott W (1971) Protective effect of L-carnitine in experimental intoxication with diphteria toxin. J Lab Clin Med 77: 616–628

    Google Scholar 

  13. Davidson D, Schultz H (1982) Separation, properties and regulation of acyl-CoA dehydrogenase from bovine heart and liver. Arch Biochem Biophys 213: 155–162

    Article  PubMed  CAS  Google Scholar 

  14. Douglas CE, Chan AC, Choy PC (1986) Vitamin E inhibits platelet phospholipase A2. Biochim Biophys Acta 876: 639–645

    Article  CAS  Google Scholar 

  15. Engel AG (1986) Carnitine deficiency syndromes and lipid storage myopathies. In: Engel AG, Banker BQ (eds) Myology; McGraw-Hill, New York, pp 1663–1696

    Google Scholar 

  16. Engel AG, Rebouche CJ, Wilson DM, Glasgow AM, Romshe CA, Cruse RP (1981) Primary systematic carnitine deficiency. II Renal handling of carnitine. Neurology 31: 819–825

    Google Scholar 

  17. Fagher B, Cederblad G, Monti, M. Olsson L, Rasmussen B, Thyssell H (1985) Carnitine and left ventricular function in haemodialysis patients. Scand J Clin Lab Invest 45: 193–198

    Article  PubMed  CAS  Google Scholar 

  18. Ferrari R, Cucchini F, Visiolo 0 (1984) The metabolic effects of L-carnitine in angina pectoris. Int J Cardiol 5: 213–216

    Article  CAS  Google Scholar 

  19. Folkers K, Wolaniuk J, Simonsen, R, Morishita M, Vadhanavikit S (1985) Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q10. Proc Natl Acad Sci USA 82: 4513–4516

    Article  PubMed  CAS  Google Scholar 

  20. Folts JD, Shug AL, Koke JR, Bittar N (1978) Protection of the ischemic dog myocardium with carnitine. Am J Cardiol 41: 1209–1214

    Article  PubMed  CAS  Google Scholar 

  21. Glasgow AM, Engel AG, Bier DM, Perry LW, Dicki M, Todaro J, Brown BI, Utter MF (1983) Hypoglycemia, hepatic dysfunction, muscle weakness, cardiomyopathy, free carnitine deficiency and long-chain carnitine excess responsive to medium chain triglyceride diet. Pediat Res 17: 319–326

    Article  PubMed  CAS  Google Scholar 

  22. Groot PHE, Scholte HR, Hülsman WC (1976) Fatty acid activation: specificity, localization and function. Adv Lipid Res 14: 75–126

    PubMed  CAS  Google Scholar 

  23. Hale DE, Batshaw ML, Coates PM, Frerman FE, Goodman SI, Sing I, Stanley CA (1985) Long-chain acyl-CoA dehydrogenase deficiency: an inherited cause of non-ketotic hypoglycemia. Pediat Res 19: 666–671

    PubMed  CAS  Google Scholar 

  24. Harano Y, Kashiwagi A, Kojima H, Suzuki M, Hashimoto T, Shigeta Y (1985) Phosphorylation of carnitine palmitoyltransferase and activation by glucagon in isolated rat hepatocytes. FEBS Lett 188: 267–272

    Article  PubMed  CAS  Google Scholar 

  25. Hart ZH, Chang C-H, DiMauro S, Farooki Q, Ayyar R (1978) Muscle carnitine deficiency and fatal cardiomyopathy. Neurology 28: 147–151

    Article  PubMed  CAS  Google Scholar 

  26. Hearse DJ, Shattoch MJ, Manning AS (1980) Carnitine in cardioplegic solutions: possible toxicity during global ischemia. J Cell Mol Cardiol 12, suppl 1: 56

    Google Scholar 

  27. Henry CG, Strauss AW, Keating JP, Hillman RE (1981) Congestive cardiomyopathy associated with 13-ketothiolase deficiency. J Pediatr 99: 754–757

    Article  PubMed  CAS  Google Scholar 

  28. Holland R, Hardie DG, Clegg RA, Zammit VA (1985) Evidence that glucagon-mediated inhibition of acetyl-CoA carboxylase in isolated hepatocytes involves increased phosphorylation of the enzyme by cyclic AMP-dependent protein kinase. Biochem J 226: 139–145

    PubMed  CAS  Google Scholar 

  29. Huijmans JGM, Schulte HR, Blom W, Luyt-Houwen IEM, Przyrembel H (1984) Enzymatic evidence for a medium-chain acyl-CoA dehydrogenase deficiency in muscle of a patient with hypoketotic hypoglycemic dicarboxylic aciduria. Pediat Res 18: 798

    Article  Google Scholar 

  30. Hülsman WC (1966) On the synthesis of malonyl-coenzyme A in rabbit heart sarcosomes. Biochim Biophys Acta 125: 398–400

    Article  Google Scholar 

  31. Hülsman WC (1978) Abnormal stress reactions after feeding diets rich in (very) long-chain fatty acids: high levels of corticosterone and testosterone. Mol Cell Endocrinol 12: 1–8

    Article  Google Scholar 

  32. Hülsman WC, Stam H, Maccari F (1982) The effect of excess (acyl)-carnitine on lipid metabolism in rat heart. Biochim Biophys Acta 713: 39–45

    Article  Google Scholar 

  33. Jennekens FGI, Scholte HR, Stinis JT, Luyt-Houwen IEM (1981) Carnitine palmitoyltransferase deficiency, variations in clinical expression, differences between CPT I and II and mode of inheritance. In: Busch HFM, Jennekens FGI, Scholte HR (eds) Mitochondria and muscular diseases, Mefar, Beetsterzwaag (The Netherlands), pp 213–218

    Google Scholar 

  34. Kolsolcharoen P, Nappi J, Peduzzi P, Shug A, Patel A, Filipek T, Thomsen JH (1981) Improved exercise tolerance after administration of carnitine. Curr Ther Res. 30: 753–764

    Google Scholar 

  35. Kudoh Y, Shoji T, Oimatsu H, Yoshida S, Kikuchi K, Iimura O (1983) The role of L-carnitine in the pathogenesis of cardiomegaly in patients with chronic hemodialysis. Jpn Circ J 47: 1391–1397

    Article  PubMed  CAS  Google Scholar 

  36. Langsjoen PH, Vadhanavikit S, Folkers K (1985) Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q1o. Proc Natl Acad Sci USA 82: 4220–4244

    Article  Google Scholar 

  37. Lauquin GJM, Villiers C, Mechejda JW, Hrniewiecka LV, Vignais PV (1977) Adenine nucleotide transport in sonic submitochondrial particles. kinetc properties and binding of specific inhibitors. Biochim Biophys Acta 460: 331–345

    Article  PubMed  CAS  Google Scholar 

  38. Liedtke AJ, Nellis SH, Whitesell LF (1981) Effects of carnitine isomers on fatty acid metabolism in ischemic swine hearts. Circ Res 48: 859–866

    Article  PubMed  CAS  Google Scholar 

  39. Long CS, Haller RG, Foster DW, McGarry JD (1982) Kinetics of carnitine-dependent fatty acid oxidation: implications for human carnitine deficiency. Neurology 32: 663–666

    Article  PubMed  CAS  Google Scholar 

  40. Maccari F, Ramacci MT (1981) Antagonism of doxorubicin cardiotoxicity by carnitine is specific of the L-diasteroisomer. Biomedicine 35: 65–67

    PubMed  CAS  Google Scholar 

  41. McGarry JD, Mills SE, Long CS, Foster DW (1983) Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Biochem J 214: 21–28

    PubMed  CAS  Google Scholar 

  42. Matsuishi T, Hirata K, Terasawa K, Kato H, Yoshino M, Ohtaki E, Hirose F (1985) Successful carnitine treatment in two siblings having lipid storage myopathy with hypertrophie cardiomyopathy. Neuropediat 16: 6–12

    Article  CAS  Google Scholar 

  43. Molstad P, Bohmer T (1981) The effect of diphteria toxin on the cellular uptake and efflux of carnitine. Evidence for a protective effect of prednisolone. Biochim Biophys Acta 641: 71–78

    Google Scholar 

  44. Morand P, Despert F, Carrier HN, Saudubray JM, Fardeau M, Romieux B, Fauchier C, Combe P. Myopathie avec cardiomyopathie sévère par déficit géneralisé en carnitine. Evolution favorable sous un traitement par chlorohydrate de carnitine. Arch Mal Coeur 5: 536–544

    Google Scholar 

  45. Moreadith RW, Batshaw ML, Ohnishi T, Kerr D, Knox B, Jackson D, Hruban R, Olson J, Reynafarje B, Lehninger AL (1984) Deficiency of the iron-sulfur clusters of mitochondrial reduced nicotinamideadenine-dinucleotide-ubiquinone oxidoreductase (complex I) in an infant with congenital lactic acidosis. J Clin Invest 47: 685–697

    Article  Google Scholar 

  46. Morgan-Hughes JA (1986) Mitochondrial diseases. TINS 9: 15–19

    CAS  Google Scholar 

  47. Morgan-Hughes JA, Hayes DJ, Cooper CM, Clark JB (1985) Mitochondrial myopathies: deficiencies localized to complex I and complex III of the mitochondrial respiratory chain. Biochem Soc Trans 13: 648–650

    PubMed  CAS  Google Scholar 

  48. Niederwieser A, Steinmann B, Exner U, Neuheiser F, Redweik U, Wang M, Rampini S, Wendel U (1983) Multiple acyl-CoA dehydrogenase deficiency in a boy with nonketotic hypoglycemia, hepatomegaly, muscle hypotonia and cardiomyopathy. Detection of N-isovalerylglutamic acid and its monamide. Helv Paediatr Acta 38: 9–26

    Google Scholar 

  49. Neely JR, Garber D, McDonough K, Idell-Wenger J (1979) Relationship between ventricular function and intermediates of fatty acid metabolism during myocardial ischemia: effects of carnitine. In: Win-bury MM, Abiko Y (eds) Ischemic myocardium and antianginal drugs, Raven Press, New York, pp 225–234

    Google Scholar 

  50. Norman J, Carrier H, Berthillier G, Bozio A, Jocteur-Monrozier D, André M, Joffre B (1979) Myocardiopathie primitive de l’enfant avec surcharge lipidique des fibres myocardiques et musculaires et mise en évidence d’un déficit en enzyme palmityl-carnitine transférase. Arch Mal Coeur 72: 529–535

    Google Scholar 

  51. Ogasahara S, Nishikawa Y, Yorifuji S, Soga F, Nakamura Y, Takahashi M, Hashimoto S, Kono N, Tarui S (1986) Treatment of Kearns-Sayre syndrome with coenzyme Q1o. Neurology 36: 45–53

    Article  PubMed  CAS  Google Scholar 

  52. Ogashara S, Yorifuji S, Nishikawa Y, Takahashi M, Wada K, Hazama T, Nakamura Y, Hashimoto S, Kono N, Tarui S (1985) Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Qio in Kearns-Sayre syndrome. Neurology 35: 372–377

    Article  Google Scholar 

  53. Opie LH (1979) Role of carnitine in fatty acid metabolism of normal and ischemic myocardium. Am J Heart 97: 375–388

    Article  CAS  Google Scholar 

  54. Pande SV, Murthy MSR, Noël H (1986) Differential effects of phosphatidylcholine and cardiolipin on carnitine palmitoyltransferase activity. Biochim Biophys Acta 877: 233–240

    Google Scholar 

  55. Papadimitriou A, Neustein HB, DiMauro S, Stanton R, Bresolin N (1984) Histocytoid cardiomyopathy of infancy: deficiency of reducible cytochrome b in heart mitochondria. Pediat Res 18: 1023–1028

    PubMed  CAS  Google Scholar 

  56. Penn D, Schmidt-Sommerfeld E, Pascu F (1981) Decreased tissue carnitine concentrations in newborn infants receiving total parenteral nutrition. J Pediat 98: 976–978

    Article  PubMed  CAS  Google Scholar 

  57. Ramos ACMF, Elias PRP, Barrucand L, Figueria da Silva JA (1984) The protective effect of carnitine in human diphteric myocarditis. Pediat Res 18: 815–819

    Article  PubMed  CAS  Google Scholar 

  58. Rebouche CJ, Engel AG (1980) Tissue distribution of carnitine biosynthetic enzymes in man. Biochim Biophys Acta 630: 22–29

    Article  PubMed  CAS  Google Scholar 

  59. Regitz V, Hodach RJ, Shug AL (1982) Carnitin-Mangel: eine behandelbare Ursache kindlicher Kardiomyopathien. Klin Wschr 60: 393–400

    Article  PubMed  CAS  Google Scholar 

  60. Rimoldi M, Bottacchi E, Rossi L, Cornelio F, Uziel G, DiDonato S (1982) Cytochrome-C-oxidase deficiency in muscles of a floppy infant without mitochondrial myopathy. J Neurol 227: 201–207

    Article  PubMed  CAS  Google Scholar 

  61. Rudman D, Sewell CW, Ansley JD (1977) Deficiency of carnitine in cachectic cirrhotic patients. J Clin Invest 60: 716–723

    Article  PubMed  CAS  Google Scholar 

  62. Sabina RL, Swain JL, Patten BM, Ashizawa T, O’Brien WE, Holmes EW (1980) Disruption of the purine nucleotide cycle. A potential explanation for muscle disfunction in myoadenylate deaminase deficiency. J Clin Invest 66: 1419–1423

    Google Scholar 

  63. Sacrez A, Porte A, Hindelang C, Bieth R, Mérian B (1982) Myocardiopathie ayes surcharge lipidique et déficit en palmityl carnitine transférase leucocytaire. Arch Mal Coeur 75: 1371–1379

    PubMed  CAS  Google Scholar 

  64. Schmidt-Sommerfeld E, Novak K, Penn D, Wieser PB, Buch M, Hahn P (1978) Carnitine and development of newborn adipose tissue. Pediat Res 12: 660–664

    Article  PubMed  CAS  Google Scholar 

  65. Scholte HR (1969) The intracellular and intramitochondrial distribution of malonyl-CoA decarboxylase and propionyl-CoA carboxylase in rat liver. Biochim Biophys Acta 178: 137–144

    Article  PubMed  CAS  Google Scholar 

  66. Scholte HR (1973) Liver malonyl-CoA decarboxylase. Biochim Biophys Acta 309: 457–465

    Article  PubMed  CAS  Google Scholar 

  67. Scholte HR (1983) Carnitine in health and disease. Neuropediatrics 14: 129

    Google Scholar 

  68. Scholte HR, Busch HFM, Barth PG, Beekman RP, Berden JA, Duran M, Luyt-Houwen IEM, Przyrembel H, Roth B, De Vries S (1983) Carnitine deficiency and mitochondrial respiratory chain blockade. In: Scarlato G, Cerri C (eds) Mitochondrial pathology in muscle diseases. Piccin, Padua, pp 215–228

    Google Scholar 

  69. Scholte HR, Busch HFM, Luyt-Houwen IEM (1981) Familial AMP deaminase deficiency with skeletal muscle type I atrophy and fatal cardiomyopathy. J Inher Metab Dis 4: 169–170

    Article  Google Scholar 

  70. Scholte HR, Busch HFM, Luyt-Houwen IEM, Vaandrager-Verduin MHM, Przyrembel H, Arts WFM (1987) Defects in oxidative phosphorylation. Biochemical investigations in skeletal muscle and expression of the lesion in other cells. J Inher Metab Dis, in press

    Google Scholar 

  71. Scholte HR, De Jonge PC (1986) Metabolism, function and transport of carnitine in health and disease. In: Gitzelmann R et al. (eds) Carnitin in der Medizin, Schattauer Verlag, Stuttgart, in press

    Google Scholar 

  72. Scholte HR, Hülsmann WC, Luyt-Houwen IEM, Stinis JT, Jennekens FGI (1985a) Carnitine palmitoyltransferase deficiencies. Biochem Soc Trans 13: 643–645

    PubMed  CAS  Google Scholar 

  73. Scholte HR, Jennekens FGI, Bouvy JJBJ (1979a) Carnitine palmitoyltransferase II deficiency with normal carnitine palmitoyltransferase I in skeletal muscle and leucocytes. J Neurol Sci 40: 39–51

    Article  PubMed  CAS  Google Scholar 

  74. Scholte HR, Luyt-Houwen IEM, Busch HFM, Jennekens FGI (1985) Muscle mitochondria from patients with Duchenne muscular dystrophy have a normal beta oxidation, but an impaired oxidative phosphorylation. Neurology 35: 1396–1397, 1808

    Google Scholar 

  75. Scholte HR, Luyt-Houwen IEM, Dubelaar M-L, Hülsmann WC (1986) The source of malonyl-CoA in rat heart. In calcium paradox releases acetyl-CoA carboxylase and not propionyl-CoA carboxylase. FEBS Lett 198: 47–50

    Google Scholar 

  76. Schultheiss HP, Bolte HD (1985) Immunological analysis of autoantibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol 17: 603–617

    Article  PubMed  CAS  Google Scholar 

  77. Schultheiss H-P, Schultze K, Klingenberg M (1986) The ADP/ATP carrier as a mitochondria] auto-antigen: facts and perspectives. Abstracts of the conference on biological membrane pathology, Como, Ann NY Acad Sci p5 (in press)

    Google Scholar 

  78. Sengers RCA, Trijbels JMF, Bakkeren JAJM, Ruitenbeek W, Fischer JC, Janssen AJM, Stadhouders AM, ter Laak HJ (1984) Deficiency of cytochromes b and aa3 in muscle from a floppy infant with cytochrome oxidase deficiency. Eur J Pediatr 141: 178–180

    Article  PubMed  CAS  Google Scholar 

  79. Shug AL, Thomson JD, Folts JD, Bittar N, Klein MI, Koke JR, Huth PJ (1978) Changes in tissue levels of carnitine and other metabolites during myocardial ischemia and anoxia. Arch Biochem Biophys 187: 25–33

    Article  PubMed  CAS  Google Scholar 

  80. Siliprandi N, di Lisa F, Toninello A (1984) Biochemical derrangements in ischemic myocardium: the role of carnitine. G Ital Cardiol 14: 804–808

    PubMed  CAS  Google Scholar 

  81. Suzuki Y, Masamura Y, Kobayashi A, Kamizaki N, Harida Y, Osawa M (1982) Myocardial carnitine deficiency in chronic heart failure. Lancet is 116

    Google Scholar 

  82. Tager JM, Wanders RJA, Groen AK, Kunz W, Bohnensack R, Mister U, Letko G, Böhme G, Duszynski J, Wojtczak L (1983) Control of mitochondria] respiration. FEBS Lett 151: 1–9

    Article  PubMed  CAS  Google Scholar 

  83. Thomsen JH, Shug AL Yap VU, Patel AK, Karras TJ, DeFelice SL (1979) Improved pacing tolerance of the ischemic human myocardium after administration of carnitine. Am J Cardiol 43: 300–306

    Article  PubMed  CAS  Google Scholar 

  84. Tripp ME, Katcher ML, Peters HA, Gilbert EF, Arya S, Hodach RI, Shug AL (1981) Systemic carnitine deficiency presenting as familial fibroelastosis. New Engl J Med 305: 385–390

    Article  PubMed  CAS  Google Scholar 

  85. Tripp ME, Shug AL (1984) Plasma carnitine concentrations in cardiomyopathy patients. Biochem Med 32: 199–206

    Article  PubMed  CAS  Google Scholar 

  86. Vacha GM, Giorcelli G, Siliprandi N, Corsi M (1983) Favorable effects of L-Carnitine treatment on hypertriglyceridemia in hemodialysis patients: decisive role of low levels of high-carnitine lipoprotein-cholesterol. Am J Clin Nutr 38: 532–540

    PubMed  CAS  Google Scholar 

  87. Van Hinsbergh VWM, Veerkamp JH, van Moerkerk HThB (1978) An accurate assay of long-chain fatty acid oxidation by human muscle. Biochem Med 20: 256–266

    Google Scholar 

  88. Van Hinsbergh VWM, Veerkamp JH, van Moerkerk HThB (1978) Palmitate oxidation by rat skeletal muscle mitochondria. Comparison of polarographic and radiochemical experiments. Arch Biochem Biophys 190: 762–771

    Google Scholar 

  89. Veerkamp JH, van Moerkerk HTB, Glatz JFC, Zuurveld JGEM, Jacobs AEM, Wagenmakers AJM (1986) 14CO2 production is no adequate measure of [14C] fatty acid oxidation. Biochem Med Metab Biol 35: 248–259

    Google Scholar 

  90. Vick JA, De Felice S, Hassett CC (1975) Prevention of adriamycin induced cardiac arrhithmias with carnitine. Physiologist 18: 431

    Google Scholar 

  91. Waber LJ, Valle D, Neill C, DiMauro S, Shug A (1982) Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport. J Pediat 101: 700–705

    Article  PubMed  CAS  Google Scholar 

  92. Ware AJ, Burton WC, McGarry JD, Markes JF, Weinberg AG (1978) Systemic carnitine deficiency. Report of a fatal case with multisystem manifestations. J Pediat 93: 959–964

    Google Scholar 

  93. Whitmer JT, Idell-Wenger JA, Rovetto MJ, Neely JE (1978) Control of fatty acid metabolism in ischemic and hypoxic hearts. J Biol Chem 253: 4305–4309

    PubMed  CAS  Google Scholar 

  94. Wit-Peeters EM, Scholte HR, Elenbaas HL (1970) Fatty acid synthesis in heart. Biochim Biophys Acta 210: 360–370

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry I, Medical Faculty, Erasmus University Rotterdam, P.O.Box 1738, 3000 DR, Rotterdam, The Netherlands

    Dr. H. R. Scholte

  2. Departments of Biochemistry I and Clinical Genetics, Medical Faculty, Erasmus University Rotterdam, The Netherlands

    Dr. H. R. Scholte, I. E. M. Luyt-Houwen & M. H. M. Vaandrager-Verduin

Authors
  1. Dr. H. R. Scholte
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. E. M. Luyt-Houwen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. H. M. Vaandrager-Verduin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

H. Stam G. J. van der Vusse

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Scholte, H.R., Luyt-Houwen, I.E.M., Vaandrager-Verduin, M.H.M. (1987). The role of the carnitine system in myocardial fatty acid oxidation: carnitine deficiency, failing mitochondria and cardiomyopathy. In: Stam, H., van der Vusse, G.J. (eds) Lipid metabolism in the normoxic and ischaemic heart. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-662-08390-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-08390-1_8

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-662-08392-5

  • Online ISBN: 978-3-662-08390-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation